Nano X Imaging Ltd (NNOX)
9.195
+0.04
(+0.38%)
USD |
NASDAQ |
May 02, 10:38
Nano X Imaging Enterprise Value: 450.36M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 450.36M |
| April 30, 2024 | 438.81M |
| April 29, 2024 | 439.96M |
| April 26, 2024 | 438.81M |
| April 25, 2024 | 436.50M |
| April 24, 2024 | 446.32M |
| April 23, 2024 | 459.03M |
| April 22, 2024 | 442.27M |
| April 19, 2024 | 418.01M |
| April 18, 2024 | 445.16M |
| April 17, 2024 | 461.34M |
| April 16, 2024 | 456.72M |
| April 15, 2024 | 448.05M |
| April 12, 2024 | 482.14M |
| April 11, 2024 | 528.36M |
| April 10, 2024 | 515.08M |
| April 09, 2024 | 540.50M |
| April 08, 2024 | 546.85M |
| April 05, 2024 | 531.25M |
| April 04, 2024 | 549.16M |
| April 03, 2024 | 548.59M |
| April 02, 2024 | 494.27M |
| April 01, 2024 | 517.96M |
| March 28, 2024 | 485.60M |
| March 27, 2024 | 491.96M |
| Date | Value |
|---|---|
| March 26, 2024 | 449.78M |
| March 25, 2024 | 484.45M |
| March 22, 2024 | 468.27M |
| March 21, 2024 | 512.76M |
| March 20, 2024 | 559.56M |
| March 19, 2024 | 546.27M |
| March 18, 2024 | 578.63M |
| March 15, 2024 | 543.96M |
| March 14, 2024 | 500.05M |
| March 13, 2024 | 489.65M |
| March 12, 2024 | 475.78M |
| March 11, 2024 | 463.07M |
| March 08, 2024 | 511.03M |
| March 07, 2024 | 512.18M |
| March 06, 2024 | 528.65M |
| March 05, 2024 | 499.47M |
| March 04, 2024 | 550.89M |
| March 01, 2024 | 563.60M |
| February 29, 2024 | 565.92M |
| February 28, 2024 | 604.63M |
| February 27, 2024 | 591.92M |
| February 26, 2024 | 471.74M |
| February 23, 2024 | 419.16M |
| February 22, 2024 | 434.76M |
| February 21, 2024 | 454.98M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
195.21M
Minimum
Oct 30 2023
3.907B
Maximum
Jan 27 2021
818.84M
Average
574.78M
Median
Enterprise Value Benchmarks
| Recursion Pharmaceuticals Inc | 1.567B |
| InMode Ltd | 711.02M |
| Inspira Technologies Oxy BHN Ltd | -- |
| SciSparc Ltd | 0.6011M |
| Can Fite Biofarma Ltd | 1.508M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.25M |
| Revenue (Quarterly) | 2.397M |
| Total Expenses (Quarterly) | 13.07M |
| EPS Diluted (Quarterly) | -0.18 |
| Gross Profit Margin (Quarterly) | -71.59% |
| Profit Margin (Quarterly) | -427.5% |
| Earnings Yield | -11.64% |
| Normalized Earnings Yield | -11.07 |